reports
Livongo Reports Third Quarter 2020 Financial Results
Livongo Reports Third Quarter 2020 Financial Results Third quarter total revenue of $106.1 million, up 126% year-over-yearOver 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-year MOUNTAIN VIEW, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (NASDAQ: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its third quarter ended September 30, 2020. “Livongo delivered another quarter of greater than 100% revenue growth, driven by stronger than...
Livongo to Release Results for the Third Quarter of Fiscal Year 2020
Livongo to Release Results for the Third Quarter of Fiscal Year 2020 MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. Given the pending transaction with Teladoc Health, Livongo is not hosting a conference call in conjunction with its third quarter of 2020 earnings release. About Livongo Livongo empowers people with chronic conditions to live better and healthier lives, beginning with diabet...
- Valens Research
Valens Equity Insights and Inflections - 2020 09 08
BHC currently trades well below corporate averages relative to Uniform earnings, with a 9.1x Uniform P/E. At these levels, the market is pricing in expectations for Uniform ROA to fall from 45% in 2019 to 20% in 2024, accompanied by 2% Uniform asset growth going forward. However, analysts have bullish expectations, projecting Uniform ROA to expand to 51% by 2021, accompanied by 3% Uniform asset shrinkage. Furthermore, management is confident about the eye health spinoff, script recovery, and Pro...
UNH UNITEDHEALTH GROUP INCORPORATED
SBGI SINCLAIR BROADCAST GROUP INC. CLASS A
LGIH LGI HOMES INC.
CTAS CINTAS CORPORATION
ARMK ARAMARK
ADP AUTOMATIC DATA PROCESSING INC.
UNP UNION PACIFIC CORPORATION
CRUS CIRRUS LOGIC INC.
LPLA LPL FINANCIAL HOLDINGS INC.
CSCO CISCO SYSTEMS INC.
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
VRX CN BAUSCH HEALTH COMPANIES INC.
SONO SONOS
FTDR FRONTDOOR INC.
LVGO LIVONGO HEALTH
Livongo to Present at Upcoming Investor Conferences
Livongo to Present at Upcoming Investor Conferences MOUNTAIN VIEW, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company, together with executives from Teladoc Health, will be presenting at the following upcoming investor conferences and discussing their pending merger: Wells Fargo Securities Healthcare Conference on Thursday, September 10 at 8:00 a.m. Eastern TimeMorgan Stanley 18th Annual Glo...
- Valens Research
LVGO - Embedded Expectations Analysis - 2020 09 02
Livongo Health, Inc. (LVGO:USA) currently trades above historical averages relative to UAFRS-based (Uniform) earnings, with a 166.3x Uniform P/E. At these levels, the market has bullish expectations for the firm, but management may be concerned about running at a net loss, Teladoc merger benefits, and the usefulness of their diabetes studies Specifically, management may lack confidence in their ability to generate a net profit, sustain Adjusted EBITDA growth, and continue generating contract wi...
Livongo to Present at Upcoming Investor Conference
Livongo to Present at Upcoming Investor Conference MOUNTAIN VIEW, Calif., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company, together with executives from Teladoc Health, will be presenting at the following upcoming investor conference: KeyBanc Capital Markets Future of Technology Series on Thursday, August 27 at 10:00 a.m. Eastern Time A live webcast of the presentation, as well as archived record...
Livongo to Present at Upcoming Investor Conference
Livongo to Present at Upcoming Investor Conference MOUNTAIN VIEW, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company, together with executives from Teladoc Health, will be presenting at the following upcoming investor conference: Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13 at 8:30 a.m. Eastern Time A live webcast of the presentation, as well as archived recordings,...
Livongo Reports Second Quarter 2020 Financial Results
Livongo Reports Second Quarter 2020 Financial Results Second quarter total revenue of $91.9 million, up 125% year-over-yearOver 410,000 enrolled Livongo for Diabetes Members, up 113% year-over-year MOUNTAIN VIEW, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (NASDAQ: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its second quarter ended June 30, 2020. “Livongo entered 2020 with significant momentum and our strong results continued during the second qua...
Livongo Announces Preliminary Second Quarter 2020 Revenue; Exceeds Pre...
Livongo Announces Preliminary Second Quarter 2020 Revenue; Exceeds Previously Announced Guidance Second Quarter 2020 Earnings Conference Call Scheduled for August 6, 2020 MOUNTAIN VIEW, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced a preliminary financial result for the second quarter of fiscal year 2020. Livongo now expects revenue for the second quarter of 2020 to be in the range of $86 million to $87 million, up from prior guidance of $73 million to $75 million. The updated revenue outlook includes approximately $2 million to $3 milli...
Livongo Studies Leverage Proprietary Data and Remote Monitoring to Rev...
Livongo Studies Leverage Proprietary Data and Remote Monitoring to Reveal Unique Diabetes Management Insights MOUNTAIN VIEW, Calif., June 18, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the findings of two studies that demonstrate how remote monitoring technologies can utilize continuous and unique data insights via its AI+AI® engine to better inform care decisions and outcomes. The research findings were presented at the American Diabe...
- Valens Research
Weekly Equity Idea Highlight - 2020 06 15
The market is expecting LVGO to see impressive expansion in returns and growth going forward, but even at current market expectations, the market does not fully capture the company's potential. LVGO has a unique subscription-based business model for the chronic healthcare space that is accelerating aggressively as telehealth needs surge. Its subscription model means that as it scales into its impressively large total addressable market, which currently is only diabetes and high blood pressure b...
Livongo Announces Pricing of Upsized $475.0 Million Convertible Senior...
Livongo Announces Pricing of Upsized $475.0 Million Convertible Senior Notes Offering MOUNTAIN VIEW, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (“Livongo”) (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the pricing of $475.0 million aggregate principal amount of 0.875% convertible senior notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The ...
Livongo Announces Proposed Offering of $400.0 Million of Convertible S...
Livongo Announces Proposed Offering of $400.0 Million of Convertible Senior Notes Due 2025 MOUNTAIN VIEW, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (“Livongo”) (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it intends to offer $400.0 million aggregate principal amount of its convertible senior notes due 2025 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities...
- Valens Research
Valens Equity Insights and Inflections - 2020 05 26
LIVN currently trades below recent averages relative to Uniform earnings, with a 31.3x Uniform P/E (Fwd V/E'). At these levels, the market is pricing in expectations for Uniform ROA to decline from 14% in 2019 to 11% in 2024, accompanied by 10% Uniform asset growth going forward. Meanwhile, analysts have similar expectations, projecting Uniform ROA to fade to 10% by 2021, accompanied by 3% Uniform asset growth. That said, management is confident about their margin improvement, capex spending, an...
PINC PREMIER INC. CLASS A
LIVN LIVANOVA PLC
LGIH LGI HOMES INC.
GOOGL ALPHABET INC. CLASS A
EXLS EXLSERVICE HOLDINGS INC.
EMR EMERSON ELECTRIC CO.
EBAY EBAY INC.
CVS CVS HEALTH CORPORATION
ARMK ARAMARK
DHI D.R. HORTON INC.
LPLA LPL FINANCIAL HOLDINGS INC.
TWTR TWITTER INC.
ASGN ASGN INC
VRX CN BAUSCH HEALTH COMPANIES INC.
LVGO LIVONGO HEALTH
Livongo to Present at Upcoming Investor Conferences
Livongo to Present at Upcoming Investor Conferences MOUNTAIN VIEW, Calif., May 26, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company will be presenting at the following upcoming investor conferences: Jefferies Virtual Healthcare Conference on Tuesday, June 2 at 2:00 p.m. Eastern TimeStifel 2020 Virtual Cross Sector Insight Conference on Wednesday, June 10 at 10:00 a.m. Eastern TimeGoldman Sachs 41st Annual G...
- Valens Research
LVGO - Embedded Expectations Analysis - 2020 05 21
Livongo Health, Inc. (LVGO:USA) currently trades above historical averages relative to UAFRS-based (Uniform) assets, with a 16.8x Uniform P/B. At these levels, the market has bullish expectations for the firm, but management may be concerned about coronavirus, member growth, and revenue guidance Specifically, management may lack confidence in their ability to sustain quarterly estimated value of agreement improvements, expand gross margins, and maintain their cash liquidity. In addition, they m...
- Dave Nicoski
- Ross LaDuke
TWOU 2U INC.
TGTX TG THERAPEUTICS INC.
SMG SCOTTS MIRACLE-GRO COMPANY CLASS A
SGMO SANGAMO THERAPEUTICS INC.
RRC RANGE RESOURCES CORPORATION
RP REALPAGE INC.
RNG RINGCENTRAL INC. CLASS A
RGR STURM RUGER & COMPANY INC.
RGEN REPLIGEN CORPORATION
PSX PHILLIPS 66
PRLB PROTO LABS INC.
NERV MINERVA NEUROSCIENCES
NBIX NEUROCRINE BIOSCIENCES INC.
MRTX MIRATI THERAPEUTICS INC.
MPWR MONOLITHIC POWER SYSTEMS INC.
MKC MCCORMICK & COMPANY INCORPORATED
LOPE GRAND CANYON EDUCATION INC.
JKHY JACK HENRY & ASSOCIATES INC.
IPHI INPHI CORPORATION
IPGP IPG PHOTONICS CORPORATION
IIVI II-VI INCORPORATED
GWPH GW PHARMACEUTICALS PLC SPONSORED ADR
FTNT FORTINET INC.
FAST FASTENAL COMPANY
EXEL EXELIXIS INC.
CYTK CYTOKINETICS INCORPORATED
CTMX CYTOMX THERAPEUTICS INC.
BOX BOX INC. CLASS A
BMY BRISTOL-MYERS SQUIBB COMPANY
BGS B&G FOODS INC.
ATRC ATRICURE INC.
ALRM ALARM.COM HOLDINGS INC.
ABMD ABIOMED INC.
SHW SHERWIN-WILLIAMS COMPANY
AEM. AGNICO EAGLE MINES LIMITED
OR OSISKO GOLD ROYALTIES LTD
ENPH ENPHASE ENERGY INC.
LSCC LATTICE SEMICONDUCTOR CORPORATION
SAM BOSTON BEER COMPANY INC. CLASS A
CENTA CENTRAL GARDEN & PET CO A
MRAM EVERSPIN TECHNOLOGIES
COUP COUPA SOFTWARE INC.
NTLA INTELLIA THERAPEUTICS INC.
AXON AXON ENTERPRISE INC
NOMDN NOMAD FOODS LTD.
MDGL MADRIGAL PHARMACEUTICALS
OKTA OKTA INC. CLASS A
KALA KALA PHARMACEUTICALS INC.
BAND BANDWIDTH CLASS A
ACMR ACM RESEARCH
AVYA AVAYA HOLDINGS
SPY SPDR S&P 500 ETF
AZN ASTRAZENECA PLC ADS
DBX DROPBOX INC. CLASS A
LASR NLIGHT
LQDA LIQUIDIA CORPORATION
CNST CONSTELLATION PHARMACEUTICALS
ESTC ELASTIC N.V.
ARAV ARAVIVE
NGM NGM BIOPHARMACEUTICALS
NIU NIU TECHNOLOGIES ADS (N SHARES)
PD PAGERDUTY
BYND BEYOND MEAT
SCPL SCIPLAY
AVTR AVANTOR INC.
FSLY FASTLY
BSGM BIOSIG TECHNOLOGIES INC
UI UBIQUITI INC.
PSN PARSONS
NVAX NOVAVAX INC.
CRNC CERENCE
DDOG DATADOG INC CLASS A
LVGO LIVONGO HEALTH
FVRR FIVERR INTERNATIONAL
AQST AQUESTIVE THERAPEUTICS
TWST TWIST BIOSCIENCE
ADPT ADAPTIVE BIOTECHNOLOGIES CORP.
REYN REYNOLDS CONSUMER PRODUCTS
SDGR INC.
SCHRÖDINGER
INC.
Livongo to Present at Upcoming Investor Conferences
Livongo to Present at Upcoming Investor Conferences MOUNTAIN VIEW, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company will be presenting at the following upcoming investor conferences: Needham Virtual Technology & Media Conference on Tuesday, May 19 at 3:15 p.m. Eastern TimeRBC Capital Markets Global Healthcare Virtual Conference on Tuesday, May 19 at 4:50 p.m. Eastern Time A live webcast...
Livongo Reports First Quarter 2020 Financial Results
Livongo Reports First Quarter 2020 Financial Results First quarter total revenue of $68.8 million, up 115% year-over-yearOver 328,000 enrolled Livongo for Diabetes Members, up 100% year-over-yearIntroduces second quarter 2020 revenue guidance of $73 million to $75 million and raises 2020 full-year revenue guidance to a range of $290 million to $303 million MOUNTAIN VIEW, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (NASDAQ: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced finan...
- Dave Nicoski
- Ross LaDuke
SHOP SHOPIFY INC.
CSX CSX CORPORATION
ADI ANALOG DEVICES INC.
WING WINGSTOP INC.
WIFI BOINGO WIRELESS INC.
USNA USANA HEALTH SCIENCES INC.
TBPH THERAVANCE BIOPHARMA INC
SCCO SOUTHERN COPPER CORPORATION
PZZA PAPA JOHN'S INTERNATIONAL INC.
PYPL PAYPAL HOLDINGS INC
PRLB PROTO LABS INC.
NGVC NATURAL GROCERS BY VITAMIN COTTAGE INC
MTLS MATERIALISE ADS
MKTX MARKETAXESS HOLDINGS INC.
MGPI MGP INGREDIENTS INC.
MANT MANTECH INTERNATIONAL CORPORATION CLASS A
LMNX LUMINEX CORP
KHC KRAFT HEINZ COMPANY
INDB INDEPENDENT BANK CORP.
HALO HALOZYME THERAPEUTICS INC.
GBCI GLACIER BANCORP INC.
FRC FIRST REPUBLIC BANK
EBS EMERGENT BIOSOLUTIONS INC.
DIOD DIODES INCORPORATED
CTLT CATALENT INC
CHTR CHARTER COMMUNICATIONS INC. CLASS A
CHMA CHIASMA
CEVA CEVA INC.
CERS CERUS CORP.
CACI CACI INTERNATIONAL INC CLASS A
ANSS ANSYS INC.
ALXN ALEXION PHARMACEUTICALS INC.
AGI. ALAMOS GOLD INC.
AAWW ATLAS AIR WORLDWIDE HOLDINGS INC.
UNP UNION PACIFIC CORPORATION
OSTK OVERSTOCK.COM INC.
LFVN LIFEVANTAGE
GFI GFI INFORMATIQUE S.A.
PJT PJT PARTNERS INC. CLASS A
CCO. CAMECO CORPORATION
MAG. MAG SILVER CORP.
DSG. DESCARTES SYSTEMS GROUP INC.
BILL BILLING SERVICES GROUP LD
CRUS CIRRUS LOGIC INC.
ENTG ENTEGRIS INC.
GLOB GLOBANT SA
LSCC LATTICE SEMICONDUCTOR CORPORATION
PETS PETMED EXPRESS INC.
SAM BOSTON BEER COMPANY INC. CLASS A
THS TREEHOUSE FOODS INC.
FIZZ NATIONAL BEVERAGE CORP.
CYRX CRYOPORT INC.
IRTC IRHYTHM TECHNOLOGIES INC.
NMI. KIRKLAND LAKE GOLD LTD.
ATGE ADTALEM GLOBAL EDUCATION INC.
SPRO SPERO THERAPEUTICS
CUE CUE BIOPHARMA INC
LBC LUTHER BURBANK CORP
TENB TENABLE HOLDINGS
LVGO LIVONGO HEALTH
FVRR FIVERR INTERNATIONAL
BIG BANK MILLENNIUM SA
ADPT ADAPTIVE BIOTECHNOLOGIES CORP.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.